150 related articles for article (PubMed ID: 31070287)
1. Chemoradiation and local recurrence of head and neck squamous cell carcinoma and the risk of carotid artery blowout.
Jacobi C; Gahleitner C; Bier H; Knopf A
Head Neck; 2019 Sep; 41(9):3073-3079. PubMed ID: 31070287
[TBL] [Abstract][Full Text] [Related]
2. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of interventions for carotid blowout syndrome in patients with head and neck cancer.
Liang NL; Guedes BD; Duvvuri U; Singh MJ; Chaer RA; Makaroun MS; Sachdev U
J Vasc Surg; 2016 Jun; 63(6):1525-30. PubMed ID: 26926937
[TBL] [Abstract][Full Text] [Related]
4. Complication of head and neck cancer: Carotid blowout syndrome.
Jonas K; Meers A; Gao M
Am J Emerg Med; 2024 Mar; 77():231.e5-231.e6. PubMed ID: 38290919
[TBL] [Abstract][Full Text] [Related]
5. Predictors of survival following carotid blowout syndrome.
Silverman DA; Parikh AS; Liu K; Zhan KY; Nimjee SM; Powers CJ; Youssef P; Rocco JW; VanKoevering KK; Kang SY; Old MO; Seim NB
Oral Oncol; 2022 Feb; 125():105723. PubMed ID: 35063883
[TBL] [Abstract][Full Text] [Related]
6. Serum albumin is an important prognostic factor for carotid blowout syndrome.
Lu HJ; Chen KW; Chen MH; Chu PY; Tai SK; Tzeng CH; Chang PM; Yang MH
Jpn J Clin Oncol; 2013 May; 43(5):532-9. PubMed ID: 23532187
[TBL] [Abstract][Full Text] [Related]
7. Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.
Mroz EA; Patel KB; Rocco JW
Cancer; 2020 Jan; 126(9):1895-1904. PubMed ID: 32083741
[TBL] [Abstract][Full Text] [Related]
8. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
Chang CL; Yuan KS; Wu SY
Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
[TBL] [Abstract][Full Text] [Related]
9. Carotid Blowout Syndrome in Head and Neck Cancer Patients: Management of Patients At Risk for CBS.
Slijepcevic AA; Roh J; Pipkorn P; Lipsey K; Bradley JP
Laryngoscope; 2023 Mar; 133(3):576-587. PubMed ID: 35575599
[TBL] [Abstract][Full Text] [Related]
10. Endovascular management of carotid blowout syndrome in patients with head and neck cancers.
Roh JL; Suh DC; Kim MR; Lee JH; Choi JW; Choi SH; Nam SY; Kim SY
Oral Oncol; 2008 Sep; 44(9):844-50. PubMed ID: 18218333
[TBL] [Abstract][Full Text] [Related]
11. A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Patil VM; Noronha V; Joshi A; Agarwal J; Ghosh-Laskar S; Budrukkar A; Murthy V; Gupta T; Mahimkar M; Juvekar S; Arya S; Mahajan A; Agarwal A; Purandare N; Rangarajan V; Balaji A; Chaudhari SV; Banavali S; Kannan S; Bhattacharjee A; D'Cruz AK; Chaturvedi P; Pai PS; Chaukar D; Pantvaidya G; Nair D; Nair S; Deshmukh A; Thiagarajan S; Mathrudev V; Manjrekar A; Dhumal S; Maske K; Bhelekar AS; Nawale K; Chandrasekharan A; Pande N; Goel A; Talreja V; Simha V; Srinivas S; Swami R; Vallathol DH; Dsouza H; Shrirangwar S; Turkar S; Abraham G; Thanky AH; Patel U; Pandey MK; Prabhash K
Cancer; 2019 Sep; 125(18):3184-3197. PubMed ID: 31150120
[TBL] [Abstract][Full Text] [Related]
12. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D
Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586
[TBL] [Abstract][Full Text] [Related]
13. Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database.
Zandberg DP; Cullen K; Bentzen SM; Goloubeva OG
Oral Oncol; 2018 Nov; 86():132-140. PubMed ID: 30409293
[TBL] [Abstract][Full Text] [Related]
14. Mono-institutional retrospective cohort analysis of the insurance status dependent access to ENT-professionals and survival in head and neck squamous cell carcinoma.
Knopf A; Teutsch S; Bier H
BMC Health Serv Res; 2021 Jan; 21(1):45. PubMed ID: 33419421
[TBL] [Abstract][Full Text] [Related]
15. Fatal carotid blowout syndrome after BNCT for head and neck cancers.
Aihara T; Hiratsuka J; Ishikawa H; Kumada H; Ohnishi K; Kamitani N; Suzuki M; Sakurai H; Harada T
Appl Radiat Isot; 2015 Dec; 106():202-6. PubMed ID: 26282568
[TBL] [Abstract][Full Text] [Related]
16. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis.
Teo M; Karakaya E; Young CA; Dyker KE; Coyle C; Sen M; Prestwich RJ
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):647-53. PubMed ID: 23948462
[TBL] [Abstract][Full Text] [Related]
18. Delayed carotid blow-out syndrome: a new complication of chemoradiotherapy treatment in pharyngolaryngeal carcinoma.
Esteller E; León X; de Juan M; Quer M
J Laryngol Otol; 2012 Nov; 126(11):1189-91. PubMed ID: 22963758
[TBL] [Abstract][Full Text] [Related]
19. A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.
Teknos TN; Grecula J; Agrawal A; Old MO; Ozer E; Carrau R; Kang S; Rocco J; Blakaj D; Diavolitsis V; Kumar B; Kumar P; Pan Q; Palettas M; Wei L; Baiocchi R; Savvides P
Invest New Drugs; 2019 Aug; 37(4):702-710. PubMed ID: 30569244
[TBL] [Abstract][Full Text] [Related]
20. Treatment modalities, adverse events, and survival outcomes in older patients with head and neck squamous cell carcinoma.
Amr S; Ioffe D; Suzuki I; Mehra R; Cullen K; Goloubeva O
Head Neck; 2021 Dec; 43(12):3935-3945. PubMed ID: 34632677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
